Clinical Trial With Riluzole in Spinocerebellar Ataxia Type 2 (ATRIL)

NCT03347344 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Spinocerebellar Ataxia Type 2

Interventions

DRUG: Riluzole
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris